Monday is all about academic (and practitioner) literature at Abnormal Returns. You can check out last week’s links including a look why ticker symbols matter.
online pharmacy buy priligy no prescription
online pharmacy buy lasix online no prescription pharmacy
online pharmacy buy wellbutrin no prescription online pharmacy
Quote of the Day
"So, the simple advice to advisors and investors is to take any investment themes supported by academic research with a huge grain of salt."
(Andrew Beer)
Portfolio management
- Rebalancing is not a sure thing. (gf-cap.com)
- Why not focus risk-parity on drawdowns? (mrzepczynski.blogspot.com)
- How to think about hedge fund classification. (mrzepczynski.blogspot.com)
Research links
- Since the market portfolio changes over time, active managers have the potential to outperform. (papers.ssrn.com)
- Why value stocks sucked wind during the Dotcom bubble. (blog.alphaarchitect.com)
- Are DCF models irrevocably broken in a zero interest rate world? (ftalphaville.ft.com)
- What matters for anomalies: shocks to cash flows or discount rates? (papers.ssrn.com)
- How to measure momentum for stock picking purposes? (blog.alphaarchitect.com)
- A deep dive into the opportunities in closed-end funds. (blog.alphaarchitect.com)
- What's actually in your multi-factor ETF? (blog.thinknewfound.com)
- Credit markets price in the downside risk of an LBO. (papers.ssrn.com)
- Should you ignore academic research? (investmenteurope.net)







